Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List

Ixabepilone and Pemetrexed/Solid Tumors

Conditions: Advanced Solid Tumors
Start Date:
Phase: Phase I
Status: Withdrawn
NCT ID: NCT01170871
Study Type: Interventional
Intervention: Drug: Ixabepilone|Drug: Pemetrexed
Study Design: Allocation: Non-Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Results: No Results Available
Sponsors: USC/Norris Comprehensive Cancer Center
Ages: Adult|Senior
Enrollment: 34
Funded By: Other
First Received: November 4, 2009
End Date:
Last Updated: July 23, 2010
Last Verified: July 1, 2010

Mesothelioma
Lawsuit Evaluation

First Name
Last Name
Phone Number
Email
Zip Code
Details:
Please Include Diagnosis Date
Type The Number Below: